MKI67 and neoplasm: Accompanying the reduction in tumor growth, Ki-67+ proliferating cells were significantly (p < .01) reduced in the Ad(s)CD115 group (14.8 ± 5.3 cells/section) compared with the AdCntl group (46 ± 13.8; Fig. 5C).